Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 8/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | TACR3 | P29371 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CCKBR | P32239 | 5/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | CCKAR | P32238 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29311674 | 0.92 | CTSB (0.40) | KEAP1CTSB | |
| SCHEMBL29312741 | 0.92 | KEAP1 (0.42) | KEAP1TACR3CCKBR | |
| SCHEMBL29312765 | 0.92 | KEAP1 (0.42) | KEAP1TACR3CCKBR | |
| SCHEMBL29311676 | 0.92 | CTSB (0.40) | KEAP1CTSB | |
| SCHEMBL29312735 | 0.91 | CTSB (0.47) | KEAP1CTSB | |
| SCHEMBL27274319 | 0.91 | CTSB (0.47) | KEAP1CTSB | |
| SCHEMBL27273315 | 0.91 | KEAP1 (0.46) | KEAP1PTPN1TACR3CCKBR | |
| SCHEMBL29312729 | 0.91 | KEAP1 (0.46) | KEAP1PTPN1TACR3CCKBR | |
| SCHEMBL29313775 | 0.89 | KEAP1 (0.45) | KEAP1CCKBRCTSB | |
| SCHEMBL29311718 | 0.88 | CCKBR (0.43) | KEAP1OPRD1PTPN1TACR3CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | KEAP1 1835/4885OPRD1 3695/4885OPRM1 3615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.